DS
ZLAB icon

David Shaw’s Zai Lab ZLAB Stock Holding History

David Shaw’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Buy
141,158
+77,915
+123% +$1.54M ﹤0.01% 2949
2026
Q1 		$1.19M Sell
63,243
-175,366
-73% -$3.25M ﹤0.01% 3316
2025
Q4 		$4.21M Buy
238,609
+204,319
+596% +$4.78M ﹤0.01% 2454
2025
Q3 		$1.16M Sell
34,290
-245,371
-88% -$8.45M ﹤0.01% 3370
2025
Q2 		$9.78M Sell
279,661
-28,294
-9% -$930K 0.01% 1512
2025
Q1 		$11.1M Buy
307,955
+234,543
+319% +$7.21M 0.01% 1312
2024
Q4 		$1.92M Buy
73,412
+64,563
+730% +$1.79M ﹤0.01% 2766
2024
Q3 		$214K Sell
8,849
-8,558
-49% -$162K ﹤0.01% 4127
2024
Q2 		$302K Buy
17,407
+2,348
+16% +$41.3K ﹤0.01% 3885
2024
Q1 		$241K Buy
+15,059
New +$317K ﹤0.01% 3833
2023
Q4 		– Sell
-13,691
Closed -$333K – 4670
2023
Q3 		$333K Sell
13,691
-40,328
-75% -$1.07M ﹤0.01% 3580
2023
Q2 		$1.5M Sell
54,019
-470
-0.9% -$15.4K ﹤0.01% 2834
2023
Q1 		$1.81M Buy
54,489
+29,576
+119% +$1.13M ﹤0.01% 2759
2022
Q4 		$765K Sell
24,913
-200
-0.8% -$6.31K ﹤0.01% 3624
2022
Q3 		$859K Sell
25,113
-76,528
-75% -$3.27M ﹤0.01% 3699
2022
Q2 		$3.52M Buy
101,641
+53,349
+110% +$1.88M ﹤0.01% 2555
2022
Q1 		$2.12M Buy
48,292
+460
+1% +$22.2K ﹤0.01% 3235
2021
Q4 		$3.01M Sell
47,832
-150,181
-76% -$12.7M ﹤0.01% 2953
2021
Q3 		$20.9M Buy
198,013
+150,280
+315% +$21.6M 0.02% 996
2021
Q2 		$8.45M Sell
47,733
-136,499
-74% -$22M 0.01% 1639
2021
Q1 		$24.6M Sell
184,232
-42,282
-19% -$6.55M 0.02% 827
2020
Q4 		$30.7M Buy
226,514
+49,137
+28% +$5M 0.03% 737
2020
Q3 		$14.8M Buy
177,377
+102,455
+137% +$8.23M 0.02% 993
2020
Q2 		$6.15M Sell
74,922
-62,925
-46% -$4.26M 0.01% 1510
2020
Q1 		$7.1M Buy
137,847
+107,373
+352% +$5.6M 0.01% 1206
2019
Q4 		$1.27M Sell
30,474
-8,818
-22% -$326K ﹤0.01% 2814
2019
Q3 		$1.27M Buy
39,292
+24,359
+163% +$836K ﹤0.01% 2686
2019
Q2 		$521K Buy
+14,933
New +$440K ﹤0.01% 3058
2018
Q4 		– Sell
-36,369
Closed -$708K – 4035
2018
Q3 		$708K Buy
+36,369
New +$789K ﹤0.01% 2905
2018
Q1 		– Sell
-10,243
Closed -$217K – 3818
2017
Q4 		$217K Buy
+10,243
New +$272K ﹤0.01% 3404

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

David Shaw's ZLAB Position: Q2 2026 in Review

David Shaw increased its Zai Lab (ZLAB) stake by 123% in Q2 2026, buying an estimated $1.54M and bringing the position to 141,158 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2949.

David Shaw first reported a position in ZLAB in Q4 2017 and has held it in 30 quarters since. The position peaked at $30.7M in Q4 2020. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • David Shaw held 141,158 shares of Zai Lab worth $2.68M as of Q2 2026.
  • David Shaw bought 77,915 Zai Lab shares in Q2 2026, an estimated $1.54M.
  • Zai Lab made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2949 holding.
  • David Shaw first reported a position in Zai Lab in Q4 2017 and has held it in 30 quarters since.
  • David Shaw's Zai Lab position peaked at $30.7M in Q4 2020.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.